Table 2.
Effects of supplementing cows with inorganic (INO, n = 11) or complexed (AAC, n = 9) trace minerals during the peripartal period on mRNA expression (fold-change relative to -30 d prepartum) of genes related with inflammation response, oxidative stress, eicosanoids, transcription factors, receptors and glucose metabolism in polymorphonuclear leukocytes (PMNL)
| Gene | Treatments | SEMa | P value1 | |||
|---|---|---|---|---|---|---|
| INO | AAC | Treatment | Time | T × Tb | ||
| Inflammation | ||||||
| DDX58 | 1.02 | 1.59 | 0.21 | 0.05 | 0.01 | 0.40 |
| IPS1 | 0.80 | 1.00 | 0.13 | 0.23 | 0.41 | 0.22 |
| NFKB1 | 0.89 | 0.91 | 0.06 | 0.75 | 0.03 | 0.74 |
| STAT3 | 1.17 | 1.09 | 0.12 | 0.62 | 0.62 | 0.84 |
| TLR2 | 1.27 | 1.21 | 0.25 | 0.85 | 0.84 | 0.41 |
| TLR4 | 1.14 | 1.43 | 0.30 | 0.48 | 0.11 | 0.49 |
| TNF | 1.33 | 0.82 | 0.25 | 0.14 | 0.99 | 0.68 |
| ZBP1 | 0.97 | 0.66 | 0.13 | 0.09 | 0.15 | 0.62 |
| Oxidative stress | ||||||
| MPO | 0.66 | 0.83 | 0.18 | 0.48 | <0.01 | 0.03 |
| NFE2L2 | 1.32 | 1.57 | 0.30 | 0.54 | 0.15 | 0.70 |
| NOX1 | 0.97 | 0.99 | 0.26 | 0.94 | 0.61 | 0.12 |
| S100A8 | 2.05 | 1.90 | 0.40 | 0.78 | 0.08 | 0.98 |
| SOD1 | 0.73 | 0.91 | 0.09 | 0.14 | 0.02 | 0.94 |
| SOD2 | 1.38 | 1.72 | 0.22 | 0.27 | 0.70 | 0.99 |
| SOD3 | 0.66 | 0.06 | 0.31 | 0.15 | 0.32 | 0.70 |
| Eicosanoids | ||||||
| ALOX5AP | 0.98 | 1.28 | 0.12 | 0.09 | 0.10 | 0.35 |
| LTA4H | 0.71 | 0.67 | 0.10 | 0.76 | <0.01 | 0.18 |
| PLA2G4A | 0.84 | 1.23 | 0.15 | 0.06 | 0.22 | 0.23 |
| PTGS2 | 0.93 | 1.30 | 0.46 | 0.53 | 0.04 | 0.93 |
| Transcription factors | ||||||
| PPARA | 1.03 | 0.63 | 0.14 | 0.04 | 0.01 | 0.21 |
| PPARD | 1.14 | 1.23 | 0.16 | 0.71 | 0.30 | 0.74 |
| PPARG | 0.84 | 1.68 | 0.33 | 0.09 | 0.80 | 0.79 |
| RXRA | 1.21 | 1.03 | 0.11 | 0.22 | 0.05 | 0.78 |
| Receptors | ||||||
| ADORA1 | 1.08 | 1.55 | 0.14 | 0.01 | 0.08 | 0.15 |
| ENTPD1 | 1.14 | 1.64 | 0.23 | 0.12 | 0.34 | 0.80 |
| IL10 | 1.37 | 1.36 | 0.20 | 0.95 | 0.16 | 0.85 |
| IL1B | 1.22 | 1.76 | 0.45 | 0.38 | 0.51 | 0.77 |
| ITGAM | 0.75 | 0.78 | 0.07 | 0.74 | 0.10 | 0.32 |
| ITGB2 | 0.99 | 0.86 | 0.08 | 0.22 | 0.34 | 0.29 |
| P2RY11 | 1.02 | 0.89 | 0.18 | 0.60 | 0.14 | 0.44 |
| PANX1 | 0.86 | 0.95 | 0.13 | 0.61 | 0.02 | 0.15 |
| SELL | 1.41 | 1.66 | 0.41 | 0.65 | 0.27 | 0.80 |
| TLN1 | 0.93 | 1.04 | 0.03 | 0.01 | 0.60 | 0.74 |
| VCL | 0.74 | 0.83 | 0.06 | 0.25 | <0.01 | 0.76 |
| Glucose metabolism | ||||||
| LDHA | 1.37 | 0.84 | 0.20 | 0.06 | 0.04 | 0.95 |
| SLC2A1 | 0.83 | 0.56 | 0.06 | <0.01 | <0.01 | <0.01 |
1 P values represents the probability of statistical significance for the fixed effects (treatment, time, treatment × time). Statistical differences were declared significant at P ≤ 0.05 and tendencies at P ≤ 0.10
aLargest standard error of the mean is shown
bInteraction of treatment × time